Cargando…
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy
Extramammary Paget disease (EMPD) is a locally aggressive cutaneous malignancy that usually arises in anogenital or axillary skin. Immune checkpoint inhibitors targeting programmed cell death receptor (PD-1) and/or its ligand (PD-L1) are approved for the treatment of several types of cancer, and res...
Autores principales: | Mauzo, Shakuntala H., Tetzlaff, Michael T., Milton, Denái R., Siroy, Alan E., Nagarajan, Priyadharsini, Torres-Cabala, Carlos A., Ivan, Doina, Curry, Jonathan L., Hudgens, Courtney W., Wargo, Jennifer A., Sahin, Aysegul A., Pettaway, Curtis A., Prieto, Victor G., Aung, Phyu P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627796/ https://www.ncbi.nlm.nih.gov/pubmed/31146499 http://dx.doi.org/10.3390/cancers11060754 |
Ejemplares similares
-
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
Extramammary Perianal Paget's Disease
por: Al Hallak, M.N., et al.
Publicado: (2009) -
Mammary and extramammary Paget's disease()
por: Lopes, Lauro Lourival, et al.
Publicado: (2015) -
PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma
por: Nagarajan, Priyadharsini, et al.
Publicado: (2019) -
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma
por: Pradhan, Dinesh, et al.
Publicado: (2019)